keyword
https://read.qxmd.com/read/38420351/racial-disparities-in-surgical-management-for-early-stage-laryngeal-squamous-cell-carcinoma-and-recurrent-dysplasia
#21
JOURNAL ARTICLE
Thomas F Cyberski, Alexander Z Wang, Brandon J Baird
OBJECTIVE: The aim of this study is to evaluate the association between race and the treatment of laryngeal dysplasia and early-stage laryngeal squamous cell carcinoma (LSCC). STUDY DESIGN: Retrospective Cohort Study. SETTING: Large multispecialty academic medical center. METHODS: Patients were treated for laryngeal dysplasia or LSCC between September 2019 and September 2022. A retrospective chart review was conducted to collect demographic and clinical information...
2024: OTO Open
https://read.qxmd.com/read/38387811/disease-control-and-late-toxicity-in-adaptive-dose-painting-by-numbers-versus-nonadaptive-radiation-therapy-for-head-and-neck-cancer-a-randomized-controlled-phase-2-trial
#22
JOURNAL ARTICLE
Aurélie De Bruycker, Wilfried De Neve, Jean-François Daisne, Tom Vercauteren, Werner De Gersem, Luiza Olteanu, Dieter Berwouts, Stéphanie Deheneffe, Indira Madani, Ingeborg Goethals, Fréderic Duprez
PURPOSE: Local recurrence remains the main cause of death in stage III-IV nonmetastatic head and neck cancer (HNC), with relapse-prone regions within high 18 F-fluorodeoxyglucose positron emission tomography (18 F-FDG-PET)-signal gross tumor volume. We investigated if dose escalation within this subvolume combined with a 3-phase treatment adaptation could increase local (LC) and regional (RC) control at equal or minimized radiation-induced toxicity, by comparing adaptive 18 F-FDG-PET voxel intensity-based dose painting by numbers (A-DPBN) with nonadaptive standard intensity modulated radiation therapy (S-IMRT)...
February 21, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38386337/neighborhood-deprivation-and-symptoms-psychological-distress-and-quality-of-life-among-head-and-neck-cancer-survivors
#23
JOURNAL ARTICLE
Zainab Balogun, Lauren A Gardiner, Jinhong Li, Elizabeth A Moroni, Margaret Rosenzweig, Marci Lee Nilsen
IMPORTANCE: Socioeconomic deprivation is associated with increased risk of poor health and quality-of-life (QOL) outcomes in head and neck cancer (HNC) survivors. However, there are few data on how neighborhood deprivation affects patient-reported outcome measures (PROMs) in HNC survivors. OBJECTIVE: To investigate whether neighborhood socioeconomic deprivation is associated with symptom burden, psychological distress, and QOL among HNC survivors. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used prospectively collected data from patients seen in a university-affiliated multidisciplinary HNC survivorship clinic between September 2018 and September 2021 who received radiotherapy for squamous cell carcinoma of the oral cavity, oropharynx, and larynx or hypopharynx...
February 22, 2024: JAMA Otolaryngology—Head & Neck Surgery
https://read.qxmd.com/read/38386208/awake-endoscopic-laser-surgery-for-early-glottic-carcinoma
#24
JOURNAL ARTICLE
Petru Gurău
The objective of this study was to demonstrate the oncologic efficacy of awake endoscopic laryngeal surgery in the treatment of T1-T2 glottic carcinoma. This is a retrospective study. Seventy-one patients with early glottic carcinoma (T1a- 26, T1b- 18, T2- 27) who underwent awake flexible endoscopic laryngeal surgery under local anesthesia and mild intravenous sedation were included in the study. In 64 cases (90.1%) only endoscopic tumor ablation by Nd:YAG laser (in 32.4% of cases being preceded by diathermy snare excision) was performed, and in 7 T2 cases postoperative radiotherapy was also offered...
February 22, 2024: Lasers in Medical Science
https://read.qxmd.com/read/38373810/case-with-translating-to-multiple-myeloma-at-8-years-after-radiation-therapy-for-extramedullary-plasmacytoma-of-the-larynx
#25
JOURNAL ARTICLE
Takeshi Kusunoki, Ryo Wada
We report a case of extramedullary plasmacytoma of the larynx that was eradicated by radiotherapy; however, 8 years later, the disease had progressed to multiple myeloma. A mid -60s Japanese woman presented with a right-sided arytenoid mass in the larynx who underwent biopsy at another hospital. Based on the biopsy results, the patient was diagnosed with extramedullary plasma cell tumour and was referred to the Department of Otorhinolaryngology at our hospital. She received radiotherapy (50.4 Gy) and the laryngeal tumour was eradicated...
February 19, 2024: BMJ Case Reports
https://read.qxmd.com/read/38366759/decisional-conflict-in-patients-with-advanced-laryngeal-carcinoma-a-multicenter-study
#26
JOURNAL ARTICLE
Anne N Heirman, Daan P de Kort, Japke F Petersen, Abrahim Al-Mamgani, Simone E J Eerenstein, Bertram J de Kleijn, Frank Hoebers, Bernard M Tijink, Martijn M Stuiver, Lisette van der Molen, Richard Dirven, Gyorgy B Halmos, Michiel W M van den Brekel
OBJECTIVES: Decision-making for patients with a locally advanced laryngeal carcinoma (T3 and T4) is challenging due to the treatment choice between organ preservation and laryngectomy, both with different and high impact on function and quality of life (QoL). The complexity of these treatment decisions and their possible consequences might lead to decisional conflict (DC). This study aimed to explore the level of DC in locally advanced laryngeal carcinoma patients facing curative decision-making, and to identify possible associated factors...
February 17, 2024: Laryngoscope
https://read.qxmd.com/read/38341096/tumor-volume-and-cancer-stem-cell-expression-as-prognostic-markers-for-high-dose-loco-regional-failure-in-head-and-neck-squamous-cell-carcinoma-a-dahanca-19-study
#27
JOURNAL ARTICLE
Morten Horsholt Kristensen, Mia Kristina Sørensen, Trine Tramm, Jan Alsner, Brita Singers Sørensen, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, Maria Andersen, Jacob Kinggaard Lilja-Fischer, Anne Ivalu Sander Holm, Eva Samsøe, Christian Rønn Hansen, Ruta Zukauskaite, Jens Overgaard, Jesper Grau Eriksen
BACKGROUND AND PURPOSE: Reliable and accessible biomarkers for patients with Head and Neck Squamous Cell Carcinoma (HNSCC) are warranted for biologically driven radiotherapy (RT). This study aimed to investigate the prognostic value of putative cancer stem cell (CSC) markers, hypoxia, and tumor volume using loco-regional high-dose failure (HDF) as endpoint. MATERIALS AND METHODS: Tumor tissue was retrieved from patients treated with primary chemo-(C-)RT and nimorazole for HNSCC in the Danish Head and Neck Cancer Study Group (DAHANCA) 19 study...
February 9, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38326581/prevalence-of-obstructive-sleep-apnea-after-treatment-for-advanced-t-stage-head-and-neck-cancer
#28
JOURNAL ARTICLE
R T Karsten, J A Rijken, I Toprak, E Kant, R de Bree, L E Smeele, M W M van den Brekel, N de Vries, M J L Ravesloot
PURPOSE: Treatment of head and neck cancer (HNC) may lead to obstructive sleep apnea (OSA), but conclusive results on the prevalence of OSA are lacking. The objective of this study is to investigate the prevalence of OSA in a cohort of patients treated for advanced T-stage HNC. METHODS: A cross-sectional study was conducted in two tertiary cancer care centers including patients at least 1 year after treatment with curative intent with surgery and/or (chemo)radiotherapy ((C)RT) for advanced T-staged (T3-4) cancer of the oral cavity, oropharynx, hypopharynx, or larynx...
February 7, 2024: European Archives of Oto-rhino-laryngology
https://read.qxmd.com/read/38326404/re-irradiation-for-isolated-neck-recurrence-in-head-and-neck-tumor-impact-of-rn-category
#29
JOURNAL ARTICLE
Hideya Yamazaki, Gen Suzuki, Norihiro Aibe, Hiroya Shiomi, Ryoong-Jin Oh, Ken Yoshida, Satoaki Nakamura, Koji Konishi, Tomohiko Matsuyama, Mikio Ogita
Unresectable, isolated lymph node recurrence after radiotherapy is rare but a candidate for re-irradiation. However, severe toxicity is anticipated. Therefore, this study aimed to explore the efficacy and toxicity of re-irradiation in isolated lymph node recurrence of head and neck lesions. We analyzed 46 patients who received re-irradiation for lymph node recurrence without local progression. The primary tumor sites included the oral cavity in 17 patients, the hypopharynx in 12, the oropharynx in seven, the larynx in three, the nasopharynx in two, and other sites...
February 7, 2024: Scientific Reports
https://read.qxmd.com/read/38308063/omission-of-radiotherapy-to-lymph-node-level-iii-in-patients-with-cn0-adenoid-cystic-carcinoma-of-the-major-salivary-gland-a-single-center-experience
#30
JOURNAL ARTICLE
Zichen Qiu, Zheng Wu, Xiong Zhou, Yalan Tao, Yong Su
PURPOSE: Due to the rarity of adenoid cystic carcinoma (ACC) of the major salivary gland, there is no consensus on the extent of prophylactic neck irradiation (PNI) for patients with clinically negative lymph nodes (cN0) disease. MATERIALS AND METHODS: We conducted a retrospective analysis of all patients with ACC of the major salivary gland who received treatment at our center between January 2010 and April 2020. The primary endpoint was regional failure-free survival (RRFS)...
February 2024: La Radiologia Medica
https://read.qxmd.com/read/38294703/minimal-invasive-laser-resection-vs-radiotherapy-as-primary-treatment-of-early-glottic-cancer-a-population-based-study-with-up-to-16-years-follow-up-of-survival-rate-of-laryngectomy-and-voice-function
#31
JOURNAL ARTICLE
Roland Rydell, Josefine Andreasson, Sara Gustafsson Baldwin, Nathalie Clarhed
BACKGROUND: Early glottic cancer can be treated with laser resection or radiotherapy. In an earlier study, we found that voice function after laser resection was inferior to that after radiotherapy. OBJECTIVES: This study was designed to determine if reduced margins at laser resection improved voice function without impairing oncologic results. METHOD: A total of 268 patients with previously untreated T1-T2 glottic carcinoma were studied. They were primarily treated with either radiotherapy ( n  = 119) or laser resection ( n  = 149)...
January 31, 2024: Acta Oto-laryngologica
https://read.qxmd.com/read/38293584/a-multi-centric-dataset-on-patient-individual-pathological-lymph-node-involvement-in-head-and-neck-squamous-cell-carcinoma
#32
JOURNAL ARTICLE
Roman Ludwig, Adrian Schubert, Dorothea Barbatei, Laurence Bauwens, Sandrine Werlen, Olgun Elicin, Matthias Dettmer, Philippe Zrounba, Panagiotis Balermpas, Bertrand Pouymayou, Vincent Grégoire, Roland Giger, Jan Unkelbach
DATASET: We provide a dataset on lymph node metastases in 968 patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC). All patients received neck dissection and we report the number of metastatic versus investigated lymph nodes per lymph node level (LNL) for every individual patient. Additionally, clinicopathological factors including T-category, primary tumor subsite (ICD-O-3 code), age, and sex are reported for all patients. The data is provided as three datasets: Dataset 1 contains 373 HNSCC patients treated at Centre Léon Bérard (CLB), France, with primary tumor location in the oral cavity, oropharynx, hypopharynx, and larynx...
February 2024: Data in Brief
https://read.qxmd.com/read/38290926/impact-of-the-sars-covid-19-pandemic-on-the-early-diagnosis-of-laryngeal-tumors-data-from-monocentric-tertiary-care-hospital-of-south-italy
#33
JOURNAL ARTICLE
Cosimo Galletti, Laura De Marco, Francesco Ciodaro, Francesco Freni, Carmelo Saraniti, Francesco Galletti, Bruno Galletti
OBJECTIVE: The aim of this retrospective case-control study is to investigate how the Sars-COVID-19 pandemic has influenced the delay in the early diagnosis of laryngeal cancer in patients who visited the University Hospital "G. Martino" in the last 3 years of the pandemic. It is also proposed to compare the diagnosis, surgical staging, and therapeutic approach offered to patients affected by laryngeal cancer in the years affected by the COVID-19 pandemic compared to cases treated during the 3 years preceding the pandemic METHODOLOGY/PRINCIPAL: A single-center retrospective study was carried out to analyze the effects of the COVID-19 pandemic on the diagnosis and treatment of patients with squamous cell carcinoma of the larynx at our Otorhinolaryngology Division of the "Gaetano Martino" University hospital...
January 30, 2024: Journal of Voice
https://read.qxmd.com/read/38263237/cone-beam-ct-based-adaptive-intensity-modulated-proton-therapy-assessment-using-automated-planning-for-head-and-neck-cancer
#34
JOURNAL ARTICLE
Yihang Xu, William Jin, Michael Butkus, Mariluz De Ornelas, Jonathan Cyriac, Matthew T Studenski, Kyle Padgett, Garrett Simpson, Stuart Samuels, Michael Samuels, Nesrin Dogan
BACKGROUND: To assess the feasibility of CBCT-based adaptive intensity modulated proton therapy (IMPT) using automated planning for treatment of head and neck (HN) cancers. METHODS: Twenty HN cancer patients who received radiotherapy and had pretreatment CBCTs were included in this study. Initial IMPT plans were created using automated planning software for all patients. Synthetic CTs (sCT) were then created by deforming the planning CT (pCT) to the pretreatment CBCTs...
January 23, 2024: Radiation Oncology
https://read.qxmd.com/read/38197296/xevinapant-plus-radiotherapy-in-resected-high-risk-cisplatin-ineligible-la-scchn-the-phase-iii-xray-vision-study-design
#35
REVIEW
Robert L Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makoto Tahara, Sue S Yom, Robert Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
There is a significant unmet need and lack of treatment options for patients with resected, high-risk, cisplatin-ineligible locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). Xevinapant, a first-in-class, potent, oral, small-molecule IAP inhibitor, is thought to restore cancer cell sensitivity to chemotherapy and radiotherapy in clinical and preclinical studies. We describe the design of XRay Vision (NCT05386550), an international, randomized, double-blind, phase III study. Approximately 700 patients with resected, high-risk, cisplatin-ineligible LA SCCHN will be randomized 1:1 to receive 6 cycles of xevinapant or placebo, in combination with radiotherapy for the first 3 cycles...
January 10, 2024: Future Oncology
https://read.qxmd.com/read/38191400/prospects-for-online-adaptive-radiation-therapy-art-for-head-and-neck-cancer
#36
JOURNAL ARTICLE
Maja Guberina, Nika Guberina, C Hoffmann, A Gogishvili, F Freisleben, A Herz, J Hlouschek, T Gauler, S Lang, K Stähr, B Höing, C Pöttgen, F Indenkämpen, A Santiago, A Khouya, S Mattheis, M Stuschke
BACKGROUND: The aim of the present study is to examine the impact of kV-CBCT-based online adaptive radiation therapy (ART) on dosimetric parameters in comparison to image-guided-radiotherapy (IGRT) in consecutive patients with tumors in the head and neck region from a prospective registry. METHODS: The study comprises all consecutive patients with tumors in the head and neck area who were treated with kV-CBCT-based online ART or IGRT-modus at the linear-accelerator ETHOS™...
January 8, 2024: Radiation Oncology
https://read.qxmd.com/read/38155239/radiotherapy-with-or-without-chemotherapy-for-locally-advanced-head-and-neck-cancer-in-elderly-patients-analysis-of-the-head-and-neck-cancer-registry-of-japan
#37
JOURNAL ARTICLE
Koichi Yasuda, Yusuke Uchinami, Satoshi Kano, Jun Taguchi, Daisuke Kawakita, Megumi Kitayama, Kentaro Nishioka, Takashi Mori, Fuki Koizumi, Yuri Fujii, Yasushi Shimizu, Keiji Kobashi, Seiichi Yoshimoto, Ken-Ichi Nibu, Akihiro Homma, Hidefumi Aoyama
BACKGROUND: Whether concurrent chemotherapy with radiotherapy (CRT) is effective for elderly patients with head and neck cancer is a controversial topic. This study aimed to analyze the effectiveness of CRT vs. radiation therapy (RT) among elderly patients in Japan. METHODS: Data from the Head and Neck Cancer Registry of Japan were extracted and analyzed. Patients with locally advanced squamous cell carcinoma of the oropharynx, hypopharynx, or larynx who received definitive CRT or RT between 2011 and 2014 were included...
December 29, 2023: International Journal of Clinical Oncology
https://read.qxmd.com/read/38130394/mortality-patterns-of-patients-with-tonsillar-squamous-cell-carcinoma-a-population-based-study
#38
JOURNAL ARTICLE
Jia Wang, Xiaolin Li, Dongdong Niu, Jiasheng Huang, Enlin Ye, Yumei Zhao, Suru Yue, Xuefei Hou, Jiayuan Wu
OBJECTIVE: Tonsillar squamous cell carcinoma (TSCC) and second primary malignancies (SPMs) are the most common causes of mortality in patients with primary TSCC. However, the competing data on TSCC-specific death (TSD) or SPM-related death in patients with TSCC have not been evaluated. This study aimed to analyze the mortality patterns and formulate prediction models of mortality risk caused by TSCC and SPMs. METHODS: Data on patients with a first diagnosis of TSCC were extracted as the training cohort from the 18 registries comprising the Surveillance, Epidemiology, and End Results (SEER) database...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/38124322/a-case-of-subglottic-marginal-b-cell-lymphoma-with-laryngeal-amyloidosis
#39
JOURNAL ARTICLE
Xin Zhao, Yanli Yu, Wenchao Sun, Yanwen Li, Shanshan Zhang
Laryngeal mucosa-associated lymphoid tissue (MALT) is an extra-nodal margin zone B-cell lymphoma (MALT lymphoma) and a low-grade malignant lymphoma with a low incidence, the etiology of the condition remains obscure, and the process of differential diagnosis poses a significant challenge, so it is easy to miss diagnosis and misdiagnosis clinically. The present article presents a clinical case study of a patient who was diagnosed with subglottic MALT lymphoma, which was associated with laryngeal amyloidosis...
December 3, 2023: Ear, Nose, & Throat Journal
https://read.qxmd.com/read/38100260/predicting-the-need-for-a-replan-in-oropharyngeal-cancer-a-radiomic-clinical-and-dosimetric-model
#40
JOURNAL ARTICLE
Tricia A Chinnery, Pencilla Lang, Anthony C Nichols, Sarah A Mattonen
BACKGROUND: Patients with oropharyngeal cancer (OPC) treated with chemoradiation can experience weight loss and tumor shrinkage, altering the prescribed treatment. Treatment replanning ensures patients do not receive excessive doses to normal tissue. However, it is a time- and resource-intensive process, as it takes 1 to 2 weeks to acquire a new treatment plan, and during this time, overtreatment of normal tissues could lead to increased toxicities. Currently, there are limited prognostic factors to determine which patients will require a replan...
December 15, 2023: Medical Physics
keyword
keyword
30957
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.